Literature DB >> 5600

Aminopyridines and sparteine as inhibitors of membrane potassium conductance: effects on Myxicola giant axons and the lobster neuromuscular junction.

C L Schauf, C A Colton, J S Colton, F A Davis.   

Abstract

The effects of the compounds 2-, 3- and 4-aminopyridine and sparteine on membrane conductance changes were examined using both voltage-clamped Myxicola axons and the lobster neuromuscular junction. In Myxicola axons, the aminopyridines very specifically inhibited the potassium conductance when applied at concentrations of 0.1 mM to 5 mM without any apparent effect of resting membrane potential. Concentrations in excess of 5 mM were needed to inhibit noticeably the sodium conductance. Potassium conductance-voltage curves were shifted in the depolarized direction along the voltage axis with no significant change in shape. There were only minor changes in the kinetics of potassium activation. In high potassium solutions, both inward and outward potassium currents were equally sensitive to the aminopyridines. Sparteine was, in general, found to be a more potent, but somewhat less specific, inhibitor of the potassium conductance. In contrast to the aminopyridines, sparteine was more effective when applied at basic pH and in addition tended to produce a noticeable degree of potassium inactivation. When applied to the lobster neuromuscular junction, 2-aminopyridine and sparteine dramatically increased the amplitude of both excitatory and inhibitory postjunctional potentials, with little or no change in resting potential, resting input conductance, reversal potential, or miniature end plate potential amplitude or frequency. Quantal content per fiber was increased by approximately a factor of 3 for the excitatory responses.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 5600

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  22 in total

1.  Neuromuscular and cardiovascular depression produced by prolonged exposure to Polymyxin B.

Authors:  A J de Silva; C Lee
Journal:  Can Anaesth Soc J       Date:  1978-07

2.  A comparison of the facilitatory actions of 4-aminopyridine methiodide and 4-aminopyridine on neuromuscular transmission.

Authors:  A S Horn; J J Lambert; I G Marshall
Journal:  Br J Pharmacol       Date:  1979-01       Impact factor: 8.739

3.  Characteristics of sodium tail currents in Myxicola axons. Comparison with membrane asymmetry currents.

Authors:  C L Schauf; J O Bullock; T L Pencek
Journal:  Biophys J       Date:  1977-07       Impact factor: 4.033

4.  The facilitatory actions of aminopyridines and tetraethylammonium on neuromuscular transmission and muscle contractility in avian muscle.

Authors:  A L Harvey; I G Marshall
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-08       Impact factor: 3.000

5.  Activation-inactivation coupling in Myxicola giant axons injected with tetraethylammonium.

Authors:  C L Schauf; T L Pencek; F A Davis
Journal:  Biophys J       Date:  1976-09       Impact factor: 4.033

6.  Effect of 4-aminopyridine on cardiovascular functions in the dog.

Authors:  E Martínez-Aguirre; J A Wikinski; A Bello; J Izquierdo; A Garcia; H Velarde
Journal:  Can Anaesth Soc J       Date:  1981-03

7.  Presynaptic actions of 4-aminopyridine and gamma-aminobutyric acid on rat sympathetic ganglia in vitro.

Authors:  M Galvan; P Grafe; G ten Bruggencate
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

8.  Neuromuscular transmission without sodium activation of the presynaptic nerve terminal in the lobster.

Authors:  N Kawai; A Niwa
Journal:  J Physiol       Date:  1980-08       Impact factor: 5.182

9.  The actions of aminopyridines on avian muscle.

Authors:  W C Bowman; A L Harvey; I G Marshall
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

10.  Amantadine and sparteine inhibit ATP-regulated K-currents in the insulin-secreting beta-cell line, HIT-T15.

Authors:  F M Ashcroft; A J Kerr; J S Gibson; B A Williams
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.